Reporting standards for transjugular intrahepatic portosystemic shunts

Journal of Vascular and Interventional Radiology

Volumn 8, Issue 2, 1997, Pages 289-297

  Haskal, Ziv J ^a   Rees, Chet R ^b   Ring, Ernest J ^b   Saxon, Richard ^b   Sacks, David ^b   Bakal, Curtis W ^b   Becker, Gary J ^b   Burke, Dana R ^b   Cole, Patricia E ^b   Dake, Michael D ^b   Gray, Richard J ^b   Hansen, Margaret E ^b   Machan, Lindsay S ^b   Martin, Louis ^b   Marinelli, David ^b   Patel, Nilesh H ^b   Shlansky Goldberg, Richard ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCITES; ELECTROENCEPHALOGRAPHY; ENDOSCOPIC SURGERY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SAFETY; TECHNIQUE; TREATMENT OUTCOME;

EID: 12644306864     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(97)70558-X     Document Type: Article

References (74)

1. Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92:1112-1114.
2. Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO. Expandable intrahepatic portacaval shunt stents: early experience in the dog. AJR 1985; 145:821-825.
3. Richter GM, Noeldge G, Palmaz JC, Roessle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 1990; 13:200-207.
4. Ring EJ, Lake JR, Roberts JP, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992; 116:304-309.
5. LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunt (TIPS) with the Wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187:413-420.
6. Helton WS, Beishaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 165:566-571.
7. Laberge JM, Somberg KA, Lake JR, et al. 2-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108:1143-1151.
8. Haskal ZJ, Pentecost MJ, Soulen MC, Shlansky-Goldberg RD, Baum RA, Cope C. Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results. AJR 1994; 163:439-444.
9. Martin M, Zajko AB, Orons PD, et al. Transjugular intrahepatic portosystemic shunt in the manage-ment of variceal bleeding: indications and clinical results. Surgery 1993; 114:719-726.
10. Echenagusia AJ, Camunez F, Simo G, et al. Variceal hemorrhage: efficacy of transjugular intrahepatic portosystemic shunts created with Strecker stents. Radiology 1994; 192:235-240.
11. Kerns SR, Hawkins I Jr. Transjugular intrahepatic portosystemic shunt in a child with cystic fibrosis. AJR 1992; 159:1277-1278.
12. Maynar M, Cabrera J, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt: early experience with a flexible trocar/ catheter system. AJR 1993; 161: 301-306.
13. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171.
14. Rousseau H, Vinel JP, Bilbao H, et al. Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: a follow-up study. Cardiovasc Intervent Radiol 1994; 17:7-11.
15. Radosevich PM, LaBerge JM, Gordon RL. Current status and future possibilities of transjugular intrahepatic portosystemic shunts in the management of portal hypertension. World J Surg 1994; 18:785-789.
16. Noeldge G, Richter GM, Roessle M, et al. Morphologic and clinical results of the transjugular intrahepatic portosystemic stent-shunt (TIPSS). Cardiovasc Intervent Radiol 1992; 15:342-348.
17. Freedman AM, Sanyal AJ, Tisnado J, et al. Results with percutaneous transjugular intrahepatic portosystemic stent-shunts for control of variceal hemorrhage in patients awaiting liver transplantation. Transplant Proc 1993; 25:1087-1089.
18. Coldwell D, Ring E, Rees C, et al. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunts in the management of portal hypertension. Radiology 1995; 196:335-340.
19. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:1192-1197.
20. Haskal ZJ, Cope C, Shlansky-Goldberg RD, Baum R, Pentecost MJ, Soulen MC. Three-year outcome in patients undergoing TIPS placement (abstr). JVIR 1996; 7(suppl): 152.
21. Abouljoud MS, Levy MF, Rees CR, et al. A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation. Transplantation 1995; 59:226-229.
22. Cabrera J, Maynar M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110:832-839.
23. Crippin JS, Schmidt RD, Niblett RL, Rees CR. Effect of a transjugular intrahepatic portosystemic shunt on liver biochemical profiles. JVIR 1995; 6:461-464.
24. Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stentshunt for variceal haemorrhage. J Hepatol 1995; 23:123-128.
25. Miller-Catchpole R. Diagnostic and therapeutic technology assessment: transjugular intrahepatic portosystemic shunt (TIPS). JAMA 1995; 273:1824-1830.
26. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts [see comments]. Hepatology 1996; 23:32-39.
27. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122:816-822.
28. Kerlan R Jr, LaBerge JM, Gordon RL, Ring EJ. Transjugular intrahepatic portosystemic shunts: current status. AJR 1995; 164: 1059-1066.
29. Kerns SC, Sabatelli FW, Hawkins IF. Fine-needle transjugular portal venous access system. JVIR 1994; 5:835-837.
30. Orloff MJ, Bell RH. Long-term survival after emergency portacaval shunting for bleeding varices in patients with alcoholic cirrhosis. Am J Surg 1986; 151:176-183.
31. Orloff MJ, Bell RH, Hyde PV, Skivolocki WP. Long-term results of portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Ann Surg 1980; 192:325-340.
32. Rubin R, Haskal ZJ, O'Brien C, Cope C, Brass C. Transjugular intrahepatic portosystemic shunt: decreased survival for patients with high APACHE II scores. Am J Gastroenterol 1995; 90:556-563.
33. Sarfeh IJ, Rypins EB. The emergency portacaval H graft in alcoholic cirrhotic patients: influence of shunt diameter on clinical outcome. Am J Surg 1986; 152:290-293.
34. Lucey M. Liver transplantation for the alcoholic patient. Gastroenterol Clin North Am 1993; 22:243-256.
35. Lucey M. Liver transplantation for alcoholic liver disease. Baillieres Clin Gastroenterol 1993; 7:717-727.
36. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
37. Conn HO. A peek at the ChildTurcotte classification. Hepatology 1981; 1:673-676.
38. Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24: 269-276.
39. Child C. Surgery and portal hypertension. In: Dunphy J, ed. The liver and portal hypertension. Philadelphia: WB Saunders, 1964.
40. Knaus W, Draper E, Wagner D, Zimmerman J. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-825.
41. Haskal Z, Yin D, Pentecost M. Computerized logistic models for predicting patient outcomes after transjugular intrahepatic portosystemic shunts (abstr). Radiology 1995; 197(P):383.
42. Gentilini P, Laffi G. Pathophysiology and treatment of ascites and the hepatorenal syndrome. Balliere's Clin Gastroenterol 1992; 6:581-607.
43. Laffi G, La Villa G, Pinzani M, et al. Refractory ascites: definition, pathogenesis and treatment. Ann Ital Med Int 1993; 8:38-46.
44. Arroyo V, Epstein M, Gallus G, et al. Refractory ascites in cirrhosis: mechanism and treatment. Gastroenterol Int 1989; 2:195-207.
45. Nazarian G, Ferrai H, Bjarnasson H, et al. Effect of transjugular intrahepatic portosystemic shunt on quality of life. AJR 1996; 167:963-969.
46. de Bruin A, de Witte L, Stevens F, Diederiks J. Sickness impact profile: the state of the art of a generic functional status measure. Soc Sci Med 1992; 35:1003-1014.
47. Grieco A, Long C. Investigation of the Karnofsky performance status as a measure of quality of life. Health Psychology 1984; 3:129-142.
48. Carter W, Bobbitt R, Bergner M, Gilson B. Validation of an interval scaling: the sickness impact profile. Health Services Research 1976; 11:516-528.
49. Gilson B, Gilson J, Bergner M, et al. The sickness impact profile: development of an outcome measure of health care. Am J Public Health 1975; 65:1304-1310.
50. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis: results of a prospective, randomized clinical trial. Ann Surg 1994; 219:353-361.
51. Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters. Ann Surg 1986; 204:356-363.
52. Rosemurgy AS, McAllister EW, Goode SE. Direction or reversal of preshunt portal blood flow as determinants of outcome up to 1 year after small-diameter prosthetic H-graft portacaval shunt. J Surg Res 1995; 58:432-434.
53. Rails P. Color Doppler sonography of the hepatic artery and portal venous system. AJR 1990; 155:517-525.
54. Waldram R, Davis M, Nunnerley H, Williams R. Emergency endoscopy after gastrointestinal haemorrhage in 50 patients with portal hypertension. Br Med J 1974; 4:94-96.
55. Josen AS, Giuliani E, Voorhees AJ, Ferrer JJ. Immediate endoscopic diagnosis of upper gastrointestinal bleeding: its accuracy and value in relation to associated pathology. Arch Surg 1976; 111:980-986.
56. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34:585-612.
57. Peto R, Pike M, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1-39.
58. Nazarian GK, Ferral H, Castaneda-Zuniga WR, et al. Development of stenoses in transjugular intrahepatic portosystemic shunts. Radiology 1994; 192:231-234.
59. Hausegger KA, Sternthal HM, Klein GE, Karaic R, Stauber R, Zenker G. Transjugular intrahepatic portosystemic shunt: angiographic follow-up and secondary interventions. Radiology 1994; 191:177-181.
60. Foshager M, Ferrai H, Nazarian G, Castaneda-Zuniga W, Letourneau J. Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic-findings and efficacy in predicting shunt patency and stenosis. AJR 1995; 165:1-7.
61. Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994; 106:1277-1283.
62. Dodd G, Zajko AB, Orons PD, Martin MS, Eichner LS, Santaguida LA. Detection of transjugular intrahepatic portosystemic shunt dysfunction: value of duplex Doppler sonography. AJR 1995; 164:1119-1124.
63. Feldstein V, Patel M, LaBerge J. Transjugular intrahepatic portosystemic shunt: accuracy of Doppler US in determination of patency and detection of stenoses. Radiology 1996; 201:141-147.
64. Ferguson J, Jalan R, Redhead D, Hayes P, Allan P. The role of duplex and colour Doppler ultrasound in the follow-up evaluation of transjugular intrahepatic portosystemic stent shunt (TIPSS). Br J Radiol 1995; 68:587-589.
65. Garcia-Tsao G, Groszmann R, Fisher R, Conn H, Atterbury C, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5:419-424.
66. Viallet A, Marleau D, Huet M, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension: relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975; 69:1297-1300.
67. Haskal ZJ, Soulen MC, Shlansky-Goldberg RD, Cope C, Pentecost MJ, Baum RA. Good and bad splenorenal shunts: indications for variceal embolization during transjugular intrahepatic portosystemic shunt placement (abstr). Radiology 1995; 197(P):180.
68. Murphy T, Lambiase R, Dorfman G, Webb M, Haas R, Beecham R. Effect of spontaneous splenorenal shunts on portal hemodynamics: limited regression of varices after transjugular intrahepatic portosystemic shunt creation. JVIR 1995; 6:700-702.
69. Rutherford R, Becker G. Standards for evaluation and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. Radiology 1991; 181: 277-281.
70. Schultz S, Ring E. Limiting diameter in transjugular intrahepatic portosystemic shunts (abstr). Radiology 1995; 193(P):130.
71. Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. RadioGraphics 1993; 13:1185-1210.
72. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20:46-55.
73. Somberg KA, Riegler JL, Laberge JM, et al. Hepatic-encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk-factors. Am J Gastroenterol 1995; 90:549-555.
74. Conn HO. Quantifying the severity of hepatic encephalopathy. In: Conn H, Bircher J, ed. Hepatic encephalopathy: syndromes and treatment. Bloomington: Medi-Ed Press, 1994; 13-26.